Eczema Atopic Dermatitis: Clinical Trials

4 trials for Eczema Atopic Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 2
Phase 31Recruiting 1

Follow Eczema Atopic Dermatitis: new trials by email Literature Review of Eczema Atopic Dermatitis trials Research Report on Eczema Atopic Dermatitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Camoteskimab, Placebo - Atopic Dermatitis, Atopic
Phase 2RecruitingApollo Therapeutics Ltd2802026-05-282026-08-28
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
GX-03, Vehicle - Eczema Atopic Dermatitis, Eczema
Phase 2 / Phase 3RecruitingTurn Therapeutics1902025-07-112026-09-04
Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
EVO301, Placebo - Atopic Dermatitis (AD), Eczema
Phase 2CompletedEvommune, Inc.712025-02-132025-12-04
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Camoteskimab, Placebo - Atopic Dermatitis, Atopic
Phase 2CompletedApollo Therapeutics Ltd622024-05-012025-09-18

Narrower conditions

Dermatitis, Atopic (4)  ·  Eczema (4)  ·  Dermatitis (2)  ·  Skin Diseases (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hypersensitivity (4)  ·  Hypersensitivity, Immediate (4)  ·  Immune System Diseases (4)  ·  Skin Diseases, Eczematous (4)  ·  Skin Diseases, Genetic (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Dermatitis (2)  ·  Skin Diseases (2)

Sponsors

Apollo Therapeutics Ltd (2)  ·  Evommune, Inc. (1)  ·  Turn Therapeutics (1)

Countries

United States (3)  ·  Canada (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Spain (1)